Research Article

Intrabronchial Valve Treatment for Prolonged Air Leak: Can We Justify the Cost?

Table 1

Patient characteristics and demographics.

PatientsAge/genderReason for procedureTypeUnderlying lung diseaseLobe(s) treatedLeak duration before IBVValves placed ()Air leak resolved/chest tube removal (days)

148/M Air leakAPFSSP, osteosarcomaLUL, Lingula8869, 11
260/MAir leakAPFSSP, COPDRUL647, 9
351/FAir leakAPFCOPD, iatrogenicRUL1131, 2
479/MAir leakAPFAfter wedgeLUL943, 5
563/MAir leakAPFSSP, COPDRUL1531, 2
675/MAir leakAPFSSP, angiosarcomaRLL2535, 45
781/MAir leakAPFCOPD, iatrogenicLUL851, 2
838/FAir leakAPFSSP, pancreatic CARLL842, 3
948/MAir leakAPFSSP, COPDLUL1066, 7
1051/FAir leakAPFCOP, iatrogenicRML921, 2
1156/MAir leakAPFAfter lobectomyLingula1022, 3
1290/FAir leakAPF COPD, iatrogenicLUL742, 3
1365/MAir leakAPFSSP, COPDRUL1142, 3

SSP: secondary spontaneous pneumothorax.
COP: cryptogenic organizing pneumonia.
APF: alveolopleural fistula.
BPF: bronchopleural fistula.